Concepedia

Patrick R. LaFontaine

PR

3

Publications

108

Citations

3

H-Index

2018

Active since

Affiliations

Sanofi (United States)(Current)

Regeneron (United States)

Patrick R. LaFontaine is an author at Sanofi (United States) specializing in cancer therapeutics, medicine, and oncology.

Top concepts

MedicineOncologyCancer TherapyGynecologyDermatologyPublic HealthCancer ResearchCervical CancerCervical HealthRadiation Oncology

Publications per year

2018–2023

3

Publications

3

Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy

Chioniso Patience Masamha, Patrick R. LaFontaine · Journal of Cellular Biochemistry · 2018 · 62 citations

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Ana Oaknin, Bradley J. Monk, Ignace Vergote et al. · European Journal of Cancer · 2022 · 34 citations

Cervical Cancer Screening, Cervical Cancer Management, Cervical Cancer +12

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Alexander Stratigos, Aleksandar Sekulić, Ketty Peris et al. · Journal of the American Academy of Dermatology · 2023 · 12 citations · Full text

Single-arm Study, Medicine, Hedgehog Inhibitor Therapy +6

Rows per page

1–3 of 3